{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:23Z","timestamp":1792787843512,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271292"],"award-info":[{"award-number":["82271292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Shanghai Municipal Science and Technology Medical Innovation Research Project","award":["23Y21900600"],"award-info":[{"award-number":["23Y21900600"]}]},{"name":"Foundation of Shanghai Municipal Key Clinical Specialty","award":["shslczdzk06901"],"award-info":[{"award-number":["shslczdzk06901"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare the effects of inhalational anesthetics and intravenous anesthetics on the neurological function of patients with moyamoya disease (MMD) after vascular bypass surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical anesthesia data of patients were retrospectively collected. Patients who underwent bypass grafts with general anesthesia from January 1st, 2019, to December 31st, 2020, in Huashan Hospital affiliated with Fudan University, were selected. The primary endpoint was stroke incidence within seven days after anesthesia, and the secondary endpoints included transient neurological deficits (TNDs) and incidence of postoperative Epilepsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We compared the data of MMD patients who received inhalational anesthetics (Sevoflurane anesthetics,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009197, group S) and intravenous anesthetics (Propofol anesthetics,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009219, group P). The stroke incidence in the two groups (group S vs. group P) was 6.6% vs. 5.9% (OR\u2009=\u20090.893; 95% CI, 0.404\u20131.976;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.780), and the group S vs. group P of TNDs incidence was 32.5% vs. 31.1% (OR\u2009=\u20090.936; 95% CI, 0.619-0.1.415,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.753). At discharge, anesthetics didn\u2019t affect the neurological endpoint. Intravenous anesthetics provided patients with better hemodynamics compared with inhalational anesthetics during MMD vascular bypass surgery (group S vs. group P, ARV\n                      <jats:sub>SBP<\/jats:sub>\n                      : 6.4 vs. 5.2,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, ARV\n                      <jats:sub>DBP<\/jats:sub>\n                      : 3.9 vs. 3.3,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002, ARV\n                      <jats:sub>MBP<\/jats:sub>\n                      : 4.5 vs. 3.8,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001,). There were statistical no differences in the NHISS score (S group vs. P group\u2009=\u20092:1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.082) at 7 days after surgery, but mRS score (S group vs. P group\u2009=\u20092:1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) at 7 days after surgery, as well as the mRS score at 6 months of follow-up (S group vs. P group\u2009=\u20090:0,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), although the difference in scores was small.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our data indicated that both inhalational and intravenous anesthetics had protective effects on patients who underwent MMD bypass grafts. MMD patients who received inhalational anesthetics and intravenous anesthetics had similar odds of neurological deficits. When comparing long-term clinical data, most patients experience good neurological recovery after receiving inhalation or intravenous anesthesia, when compared p\n                      <jats:sub>75<\/jats:sub>\n                      mRS score(S group vs. P group\u2009=\u20093:1)in 6 month indicate that intravenous anesthetics might be more suitable for patients undergoing MMD bypass grafts. During the operation hemodynamic stability in the propofol group is greater than that in the sevoflurane anesthesia group.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-025-02958-7","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:41:26Z","timestamp":1739580086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inhalational versus intravenous anesthetic for cerebrovascular accident outcomes after surgical revascularization for adult moyamoya disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Yifei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaochao","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"2958_CR1","doi-asserted-by":"publisher","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226-37. https:\/\/doi.org\/10.1056\/NEJMra0804622. PMID: 19297575.","DOI":"10.1056\/NEJMra0804622"},{"issue":"3","key":"2958_CR2","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3892\/etm.2019.7198","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zheng L, Feng L. Epidemiology, diagnosis and treatment of moyamoya disease. Exp Ther Med. 2019;17(3):1977\u201384. https:\/\/doi.org\/10.3892\/etm.2019.7198. Epub 2019 Jan 25. PMID: 30867689; PMCID: PMC6395994.","journal-title":"Exp Ther Med"},{"issue":"3","key":"2958_CR3","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s11064-022-03822-7","volume":"48","author":"GB Fan","year":"2023","unstructured":"Fan GB, Li Y, Xu GS, Zhao AY, Jin HJ, Sun SQ, Qi SH. Propofol inhibits ferroptotic cell death through the Nrf2\/Gpx4 signaling pathway in the mouse model of cerebral ischemia-reperfusion Injury. Neurochem Res. 2023;48(3):956\u201366. https:\/\/doi.org\/10.1007\/s11064-022-03822-7. Epub 2022 Nov 19. PMID: 36402927.","journal-title":"Neurochem Res"},{"key":"2958_CR4","doi-asserted-by":"publisher","unstructured":"Xing W, Zhao J, Liu J, Liu Z, Chen G. The protective effects of sevoflurane on subarachnoid hemorrhage. Med Gas Res. 2024 Jan-Mar;14(1):1\u20135. https:\/\/doi.org\/10.4103\/2045-9912.379167. PMID: 37721248.","DOI":"10.4103\/2045-9912.379167"},{"key":"2958_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"N Hashimoto","year":"2012","unstructured":"Hashimoto N, Tominaga T, Miyamoto S, et al. Research Committee on the Pathology and Treatment of spontaneous occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on measures for Infractable diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012;52:245\u201366.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"22","key":"2958_CR6","doi-asserted-by":"publisher","first-page":"4380","DOI":"10.3390\/ijerph16224380","volume":"16","author":"A Wi\u00f3rek","year":"2019","unstructured":"Wi\u00f3rek A, Krzych \u0141J. Intraoperative blood pressure variability predicts postoperative mortality in non-cardiac Surgery-A prospective observational cohort study. Int J Environ Res Public Health. 2019;16(22):4380. https:\/\/doi.org\/10.3390\/ijerph16224380. PMID: 31717505; PMCID: PMC6888597.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2958_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10143-019-01118-z","volume":"43","author":"J Li","year":"2020","unstructured":"Li J, Zhao Y, Zhao M, Cao P, Liu X, Ren H, Zhang D, Zhang Y, Wang R, Zhao J. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease. Neurosurg Rev. 2020;43(2):759\u201369. https:\/\/doi.org\/10.1007\/s10143-019-01118-z. Epub 2019 Jun 15. PMID: 31203482.","journal-title":"Neurosurg Rev"},{"key":"2958_CR8","doi-asserted-by":"publisher","first-page":"1041886","DOI":"10.3389\/fneur.2022.1041886","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Li M, Wang J. Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: a comparative effectiveness study. Front Neurol. 2022;13:1041886. https:\/\/doi.org\/10.3389\/fneur.2022.1041886. PMID: 36601296; PMCID: PMC9807214.","journal-title":"Front Neurol"},{"issue":"7","key":"2958_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/biomedicines9070820","volume":"9","author":"K Jayaraman","year":"2021","unstructured":"Jayaraman K, Liu M, Zipfel GJ, Athiraman U. Sevoflurane and desflurane exposures following Aneurysmal Subarachnoid Hemorrhage Confer Multifaceted Protection against delayed cerebral ischemia. Biomedicines. 2021;9(7):820. https:\/\/doi.org\/10.3390\/biomedicines9070820. PMID: 34356884; PMCID: PMC8301428.","journal-title":"Biomedicines"},{"key":"2958_CR10","doi-asserted-by":"publisher","first-page":"104327","DOI":"10.1016\/j.yexmp.2019.104327","volume":"112","author":"Chang","year":"2020","unstructured":"Chang, Jianhua. Yan Xin,Zeng Yuan,Propofol weakens hypoxia-aroused apoptosis and autophagy via elevating microRNA-137 in neurocytes.[J]. Exp Mol Pathol. 2020;112:104327.","journal-title":"Exp Mol Pathol"},{"key":"2958_CR11","doi-asserted-by":"publisher","unstructured":"Hishikawa T, Sugiu K, Date I. Moyamoya Disease: A Review of Clinical Research. Acta Med Okayama. 2016;70(4):229\u2013\u200936. https:\/\/doi.org\/10.18926\/AMO\/54497. PMID: 27549666.","DOI":"10.18926\/AMO\/54497"},{"key":"2958_CR12","doi-asserted-by":"publisher","unstructured":"Fujimura M, Tominaga T. Current status of revascularization surgery for Moyamoya disease: special consideration for its \u2018internal carotid-external carotid (IC-EC) conversion\u2019 as the physiological reorganization system. Tohoku J Exp Med. 2015;236(1):45\u201353. https:\/\/doi.org\/10.1620\/tjem.236.45. PMID: 25971859.","DOI":"10.1620\/tjem.236.45"},{"key":"2958_CR13","doi-asserted-by":"crossref","unstructured":"Zhao M, Deng X, Zhang D, Wang S, Zhang Y, Wang R, Zhao J. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg. 2018 Mar 1:1\u201312. doi: 10.3171\/2017.10.JNS171749. Epub ahead of print. PMID: 29600916.","DOI":"10.3171\/2017.10.JNS171749"},{"issue":"5","key":"2958_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000336765","volume":"33","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis. 2012;33(5):436\u201345. https:\/\/doi.org\/10.1159\/000336765. Epub 2012 Mar 28. PMID: 22456617.","journal-title":"Cerebrovasc Dis"},{"key":"2958_CR15","doi-asserted-by":"crossref","unstructured":"Zhang X, Yang Y, Gan C, Risk Factors of Transient Neurological Deficits and Perioperative Stroke after Revascularization in Patients with Moyamoya Disease. Brain Sci., Katakura PMID, Kubo Y, Dobashi Y, Kimura K, Fujiwara K, Chida S, Kobayashi K, Yoshida M, Terasaki K, Ogasawara K et al. K. Delayed development of cerebral atrophy after cerebral hyperperfusion following arterial bypass for adult patients with ischemic moyamoya disease: supplementary analysis of a 5-year prospective cohort. Acta Neurochir (Wien). 2022;164(4):1037\u20131045. doi: 10.1007\/s00701-022-05141-w. Epub 2022 Feb 5. PMID: 35122551.","DOI":"10.1007\/s00701-022-05141-w"},{"key":"2958_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2176\/nmc.38.420","volume":"38","author":"M Uno","year":"1998","unstructured":"Uno M, Nakajima N, Nishi K, Shinno K, Nagahiro S. Hyperperfusion syndrome after extracranial-intracranial bypass in a patient with moyamoya disease\u2014case report. Neurol Med Chir. 1998;38:420\u20134. https:\/\/doi.org\/10.2176\/nmc.38.420","journal-title":"Neurol Med Chir"},{"key":"2958_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3171\/2014.8.JNS132413","volume":"122","author":"N Mukerji","year":"2015","unstructured":"Mukerji N, Cook D, Steinberg G. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease? J Neurosurg. 2015;122:90\u20134. https:\/\/doi.org\/10.3171\/2014.8.JNS132413","journal-title":"J Neurosurg"},{"key":"2958_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3988\/jcn.2018.14.3.393","volume":"14","author":"J Phi","year":"2018","unstructured":"Phi J, Lee S, Kang H, Kim J, Kim S, Cho W, Lee S. Postoperative transient neurologic dysfunction: a proposal for pathophysiology. J Clin Neurol. 2018;14:393\u2013400. https:\/\/doi.org\/10.3988\/jcn.2018.14.3.393","journal-title":"J Clin Neurol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-02958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-02958-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-02958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:41:39Z","timestamp":1739580099000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-025-02958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2958"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-02958-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4609181\/v1","asserted-by":"object"}]},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Huashan Hospital affiliated with Fudan University (Ethics number KY2024-795).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}